May cause grave injuries or death: USFDA classifies recall of Getinge heart devices as most serious

An estimated 4,502 devices were recalled by the Swedish medical equipment maker's unit, Datascope, in the country in January, according to the US Food and Drug Administration (FDA).

Published On 2023-04-03 07:20 GMT   |   Update On 2023-04-03 07:20 GMT
Advertisement

Bengaluru: The US health regulator on Friday classified the recall of Getinge AB's heart devices as its most serious type as their use may cause grave injuries or death due to risk of unexpected shutdowns.

The company said it has informed its customers about the issue and there was no material financial impact from the recall.

An estimated 4,502 devices were recalled by the Swedish medical equipment maker's unit, Datascope, in the country in January, according to the US Food and Drug Administration (FDA).

Advertisement

A communication loss between certain chips may result in an unexpected shutdown of the devices, which are designed to help the heart pump more blood, the agency said.

Unexpected pump shutdown and any interruption to therapy could lead to unstable blood flow, organ damage, including death, especially for critically ill people.

Datascope has reported 42 complaints about the communication failures resulting in unexpected shutdowns of the devices, distributed between March 6, 2012, and Jan. 13 of this year, the FDA said. It added there were no reports of any injuries or deaths related to the issue.

Earlier in March, the FDA had classified recall of an estimated 2,300 of these devices as most serious due to a different issue. Getinge had also recalled 4,454 units initiated back in December due to another issue.

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News